NDX-3315
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NDX-3315, covering 2025-08-11 to 2025-08-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis [Phase 2]